Skip to main content
. 2022 Nov 8;13:1011522. doi: 10.3389/fphar.2022.1011522

TABLE 2.

Baseline signs and symptoms of the patients among the studied groups.

STD (N = 30) NS (N = 30) VD (N = 30) NS + VD (N = 30) p-value
Cough, n (%) 0.93 2
 Absent 6 (20.0) 5 (16.7) 9 (30.0) 8 (26.7)
 Dry 19 (63.3) 20 (66.7) 17 (56.7) 17 (56.7)
 Productive 5 (16.7) 5 (16.7) 4 (13.3) 5 (16.7)
Diarrhea, n (%) 11 (36.7) 9 (30.0) 4 (13.3) 7 (23.3) 0.20 1
Fatigue, n (%) 30 (100.0) 28 (93.3) 29 (96.7) 27 (90.0) 0.52 2
Headache, n (%) 23 (76.7)* 16 (53.3) 13 (43.3) 14 (46.7) 0.04 2
Rash, n (%) 1 (3.3) 0 (0.0) 0 (0.0) 2 (6.7) 0.62 2
Conjunctivitis, n (%) 2 (6.7) 5 (16.7) 1 (3.3) 2 (6.7) 0.39 2
Rhinorrhea, n (%) 7 (23.3) 12 (40.0) 11 (36.7) 10 (33.3) 0.55 1
Anosmia, n (%) 14 (46.7) 17 (56.7) 14 (46.7) 14 (46.7) 0.83 1
SOB, n (%) 10 (33.3) 12 (40.0) 9 (30.0) 16 (53.3) 0.26 1
Pharyngitis, n (%) 17 (56.7) 12 (40.0) 9 (30.0) 15 (50.0) 0.17 1
Ageusia, n (%) 15 (50.0) 15 (50.0) 14 (46.7) 15 (50.0) 0.99 1
Vomiting, n (%) 3 (10.0) 4 (13.3) 3 (10.0) 3 (10.0) 1.00 2
1

Pearson’s chi-squared test.

2

Fisher’s exact test.

Abbreviations: NS, Nigella sativa; SOB, shortness of breath; STD, standard therapy; VD, vitamin D3.